Literature DB >> 32681274

Fluid restriction versus volume expansion in children with diarrhea-associated HUS: a retrospective observational study.

Pablo Bonany1, Manuel D Bilkis2, Guillermo Iglesias3, Amalia Braun3, Juliana Tello3, Viviana Ratto4, Ana Vargas5, Emilio Koch5, Patricia Jannello6, Ezequiel Monteverde7.   

Abstract

BACKGROUND: Fifty percent of patients with typical diarrhea-associated hemolytic uremic syndrome (D+HUS) require kidney replacement therapy (KRT). In these patients, dehydration worsens disease prognosis. We evaluated dialysis requirement, presence of seizures, and mortality rate among patients diagnosed with D+HUS treated with volume expansion (VE) versus fluid restriction (FR).
METHODS: Thirty-five patients with D+HUS were enrolled; 16 received VE and 19 were historical patients who received conventional FR.
RESULTS: Upon admission or during treatment, neither group presented evidence of fluid overload. The VE group received higher volumes of saline (VE 27 ml/kg [10-30] over a 3-h period vs. FR 0 ml), had higher urine output after 12 h (VE vs. FR: OR 6.2 [1.2-41.6], P = 0.03), and required less dialysis (VE 2 [12.5%, CI 95% 0-29] vs. FR 9 [47.4%, CI 95% 24-70], P = 0.035). The VE group had an absolute risk reduction of 0.34 (CI 95% 0.07-0.63); hence, three patients treated with VE were required to avoid one KRT. VE also corrected initial hyponatremia and maintained serum sodium within normal ranges. No statistical differences were observed regarding number of patients with seizures (P = 0.08) or mortality (P = 1.0).
CONCLUSIONS: VE markedly reduces the number of patients requiring KRT and keeps serum sodium within a normal range. We propose to initially hydrate every patient with D+HUS and without signs of fluid overload, with 10 ml/kg/h 0.9% saline solution IV, over a 3-h period. Afterwards, if urine output is ≥ 0.5 ml/kg/h, it is recommended to not dialyze and continue IV hydration schedule with isotonic (D5) saline solution, according to their needs.

Entities:  

Keywords:  Children; D+HUS; Dehydration; Fluid overload; Hemolytic uremic syndrome; Intravascular volume; Kidney replacement therapy

Mesh:

Substances:

Year:  2020        PMID: 32681274     DOI: 10.1007/s00467-020-04673-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  2 in total

1.  The maintenance need for water in parenteral fluid therapy.

Authors:  M A HOLLIDAY; W E SEGAR
Journal:  Pediatrics       Date:  1957-05       Impact factor: 7.124

2.  Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome.

Authors:  José M Ojeda; Isolda Kohout; Eduardo Cuestas
Journal:  Nefrologia       Date:  2013-04-05       Impact factor: 2.033

  2 in total
  2 in total

Review 1.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

2.  Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS).

Authors:  Sebastian Loos; Jun Oh; Laura van de Loo; Markus J Kemper; Martin Blohm; Raphael Schild
Journal:  Pediatr Nephrol       Date:  2021-05-27       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.